← Leaderboards
Kurt Barnhart
University Of Pennsylvania
$716,205
Attributed
$716,205
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $375.5K · FY2017–20$500K$375K$250K$125K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$716,205 · 2
By mechanism
N01$716,205 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kurt T Barnhart$21,863,411
- Christos Coutifaris$14,929,974
- Deborah B Nelson$4,439,020
- John A Detre$28,784,825
- Brian Leslie Strom$30,281,155
Others in their field
Other Emerging Leaders on “Reproductive”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Prasant Mohapatra · University Of California At Davis$56,786,398
- Greg Yothers · University Of Chicago$35,003,821
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,585,613
- Xinhua Li · Nano Terra, Inc.$11,962,715
- Barbara Burtness · Yale University$11,235,253
Research focus
ReproductiveMissionProceduresSpecific Qualifier ValueObesityDoseNational Institute Of Child Health And Human DevelopmentPregnancySamplingWomanProtocols DocumentationPharmaceutical PreparationsData ExchangeCounselingDemographicsBlood SpecimenBirth ControlAcetatesDiariesAmenorrheaBiopsyContraceptive EfficacyClinical TrialsClinical Chemistry
Grant awards (5)
CCTN - A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$200,402
N01 · FY2020 · HD · contact PI
CCTN - A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$125,137
N01 · FY2019 · HD · contact PI
LOW-COST INTERVENTION TO AUGMENT FIRST-LINE INFERTILITY TREATMENT SUCCESS: A RANDOMIZED CLINICAL TRIAL IN WOMEN WITH INFLAMMATION$210,273
N01 · FY2018 · HD · contact PI
CCTN - A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$165,260
N01 · FY2018 · HD · contact PI
CCTN - A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$15,133
N01 · FY2017 · HD · contact PI